Faes FarmaFRA:FFEA 89 Quick Ratio is 1.62 as of Dec. 2025, which is 23% below its 10-year median of 2.11. GuruFocus rates FRA:FFEA with a GF Score™ of 89/100 and a GF Value™ of €5.15 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 996 Drug Manufacturers companies, Faes Farma ranks better than 55.12% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Faes Farma's quick ratio for the quarter that ended in Dec. 2025 was 1.62.
Faes Farma has a quick ratio of 1.62. It generally indicates good short-term financial strength.
The historical rank and industry rank for Faes Farma's Quick Ratio or its related term are showing as below:
FRA:FFEA'
s Quick Ratio Range Over the Past 10 Years
Min: 1.53 Med: 2.11 Max: 3.04
Current: 1.62
During the past 13 years, Faes Farma's highest Quick Ratio was 3.04. The lowest was 1.53. And the median was 2.11.
FRA:FFEA's Quick Ratio is ranked better than 55.12% of 996
companies
in the Drug Manufacturers industry
Industry Median: 1.45
vs FRA:FFEA: 1.62
Faes Farma (FRA:FFEA) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Faes Farma Quick Ratio Related Terms
Faes Farma Quick Ratio Historical Data
* Premium members only.
The historical data trend for Faes Farma's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:FFEA vs ZTS, UTHR, VTRS: Quick Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Faes Farma's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Faes Farma Quick Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Faes Farma's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Faes Farma's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Faes Farma's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Faes Farma (FRA:FFEA) has a Quick Ratio of 1.62 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Faes Farma and its competitors. This is 23% below median its historical median of 2.11. Over the past decade, Faes Farma's Quick Ratio has ranged from 1.53 to 3.04. According to the industry distribution chart, Faes Farma ranks #447 out of 996 companies in the Drug Manufacturers industry, placing it in the top 44.9%.
Is Faes Farma's Quick Ratio too high?
Faes Farma's current Quick Ratio of 1.62 is 23% below median its 10-year median of 2.11. Over the past 10 years, this metric has ranged from a low of 1.53 to a high of 3.04. The Drug Manufacturers industry median Quick Ratio is 1.45. Faes Farma's value of 1.62 is 11.7% above this industry median. Based on the distribution chart, Faes Farma ranks #447 out of 996 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Faes Farma has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Faes Farma's Quick Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Faes Farma ranks #447 out of 996 companies for Quick Ratio. This puts Faes Farma in the upper half of its industry. The industry median Quick Ratio is 1.45. Faes Farma's value of 1.62 is 11.7% above this benchmark. Historically, Faes Farma's own Quick Ratio has ranged from 1.53 to 3.04 over the past decade. While the company's 10-year median is 2.11 vs. the industry median of 1.45, Faes Farma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Drug Manufacturers company?
The median Quick Ratio among Drug Manufacturers companies is 1.45, based on 996 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Faes Farma's current Quick Ratio of 1.62 is 11.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Faes Farma and its competitors. For the Drug Manufacturers industry, the median Quick Ratio is 1.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Faes Farma's current Quick Ratio is 1.62, which is 23% below median its own 10-year median of 2.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Faes Farma stock overvalued right now?
Based on GuruFocus' analysis, Faes Farma (FRA:FFEA) is currently considered Modestly Undervalued. The stock's GF Value™ is €5.15, compared to a current price of €4.57 — trading 11.3% below its estimated fair value. The current Quick Ratio is 1.62, which is 23% below median its 10-year median of 2.11 and 11.7% above the Drug Manufacturers industry median of 1.45. Faes Farma's overall GF Score™ is 89/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Faes Farma (FRA:FFEA), the current Quick Ratio is 1.62 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Faes Farma (FRA:FFEA) Overvalued in 2026?
Based on GuruFocus' analysis, Faes Farma stock appears to be undervalued.
The current stock price of €4.57 is trading 11.3% below its estimated GF Value™ of €5.15.
GuruFocus considers Faes Farma to be Modestly Undervalued.
Key valuation signals for FRA:FFEA:
Quick Ratio: 1.62 (23% below median its 10-year median of 2.11)
GF Value™: €5.15 vs. price of €4.57 (11.3% below fair value)
Industry Position: 11.7% above the Drug Manufacturers median (#447 of 996)
No single metric tells the full story. See the FRA:FFEA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Faes Farma SA purpose is manufacturing and selling all kinds of chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. It is mainly engaged in the manufacture and sale of pharmaceutical products, as well as in the manufacture and sale of animal nutrition and health products. Its segments are Pharmaceutical and healthcare specialities, Animal nutrition and health, and Other segments. It generates majority of revenue from Pharmaceutical and healthcare specialities. It operates mainly in domestic and international markets.
89GF Score
Get the complete analysis for FRA:FFEA
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:FFEA has been successfully added to your 
